Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review
Hematologic Oncology Update · Jan 21, 2026 · 1:01:12
Hematologic Oncology Update · Jan 21, 2026 · 1:01:12
Listen in the Podli app 🎧
Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.
Prof Michael Dickinson from Peter MacCallum Cancer Centre in Melbourne, Australia, and Dr Laurie H Sehn from the University of British Columbia in Vancouver, Canada, discuss clinical cases and recent findings from the 2025 ASH Annual Meeting relating to the use of bispecific antibodies in the management of lymphoma.
CME information and select publications here.
Episodes: Hematologic Oncology Update
